Evaluation for Insulin Resistance and Comorbidities Related to Insulin Resistance in Polycystic Ovary Syndrome -- Fat Distribution and Adipose Products in Polycystic Ovary Syndrome -- Treatment of Infertility in Polycystic Ovary Syndrome -- Imaging Studies in Polycystic Ovary Syndrome -- Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome -- Anti-Androgens -- Lipid Abnormalities in Polycystic Ovary Syndrome -- Serine Phosphorylation, Insulin Resistance, and the Regulation of Androgen Synthesis -- Chronic Treatment of Polycystic Ovary Syndrome -- Insulin-Sensitizing Drugs for the Treatment of Infertility in Polycystic Ovary Syndrome -- Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome -- Adrenarche -- Cardiovascular Disease and Inflammation -- Surgery and Laser Diathermy -- Late Pregnancy Complications in Polycystic Ovary Syndrome -- Glucose Intolerance -- Hormonal and Biochemical Evaluation of Polycystic Ovary Syndrome -- Endometrial Carcinoma in Polycystic Ovary Syndrome -- Statins, Oxidative Stress, and Polycystic Ovary Syndrome -- Glucose Intolerance in Polycystic Ovary Syndrome -- Polycystic Ovary Syndrome -- Anovulation in Polycystic Ovary Syndrome -- Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome -- "Secondary" Polycystic Ovary Syndrome -- Long-Term Sequelae of Polycystic Ovary Syndrome -- The Insulin Resistance of Polycystic Ovary Syndrome -- Therapeutic Aspects of Polycystic Ovary Syndrome in Adolescence -- Lifestyle Intervention in Polycystic Ovarian Syndrome -- Involvement of the Endocannabinoid System in Metabolism and Fertility -- Insulin Resistance -- Clinical Evaluation of Polycystic Ovary Syndrome -- Pharmaceutical Intervention in Metabolic and Cardiovascular risk Factors in Polycystic Ovary Syndrome -- Insulin Resistance and Early Pregnancy Loss in Polycystic Ovary Syndrome.